Renesas Electronics Corporation (TSE:6723), a supplier of advanced semiconductor solutions, today announced that is delivering a synchronous boost converter solution in high volume for the first at-home COVID-19 test authorized by the United States Food and Drug Administration (FDA). Renesas prioritized a steep ramp-up for this kit to meet anticipated high demand.
Testing is a key weapon in the fight against COVID-19 with over 600 million tests administered in the United States so far this year. The FDA issued an Emergency Use Authorization (EUA) to Lucira Health, Inc., a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, for its single-use, user-friendly Lucira™ COVID-19 All-In-One Test Kit that can produce a positive or negative result at home within 30 minutes. This is significantly faster than labs that currently take up to about seven days to generate similarly accurate test results. Lucira’s test kit is differentiated by its simple ‘swab, stir and detect’ design.
“We’re particularly pleased to contribute to Lucira’s important COVID-19 self-testing kit,” said Kris Rausch, Vice President of Americas Sales for the IoT and Infrastructure Business Unit at Renesas. “As part of our corporate-wide efforts, Renesas has prioritized customers and solutions that help society battle this global pandemic.”
“Delivering the first single-use, at-home, molecular test kit for COVID-19 was a tremendous achievment of which we are extremely proud,” said Erik T. Engelson, President & CEO. “It’s a testament to our technology, as well as the dedication and speed of our team. We required the same exceptional technology and speed from our suppliers, and Renesas quickly ramped-up to deliver exactly what we needed.”
